A detailed history of Range Financial Group LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Range Financial Group LLC holds 39,866 shares of EXEL stock, worth $1.5 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
39,866
Previous 35,172 13.35%
Holding current value
$1.5 Million
Previous $1.3 Million 35.36%
% of portfolio
0.75%
Previous 0.63%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 08, 2025

BUY
$34.13 - $46.26 $160,206 - $217,144
4,694 Added 13.35%
39,866 $1.76 Million
Q1 2025

Apr 14, 2025

BUY
$32.38 - $39.16 $172,164 - $208,213
5,317 Added 17.81%
35,172 $1.3 Million
Q4 2024

Jan 07, 2025

BUY
$25.39 - $36.46 $758,018 - $1.09 Million
29,855 New
29,855 $994,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $12.1B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Range Financial Group LLC Portfolio

Follow Range Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Range Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Range Financial Group LLC with notifications on news.